Table 3.
Investigations | Parameters | Results |
---|---|---|
Spirometry results | FEV1 (L) | 1.26±0.59 (n=175) |
FEV1 (%) | 42.30±18.24 (n=175) | |
FVC (L) | 2.13±0.72 (n=175) | |
FVC (%) | 56.35±17.22 (n=175) | |
FEV1/FVC<0.7 | 138/175 (78.86%) | |
FEV1/FVC ratio (mean) | 0.56±0.17 (n=175) | |
Post-bronchodilator values | ||
FEV1/FVC (mean) | 0.57±0.17 (n=156) | |
TLC (%) | 77.54±26.10 (n=39) | |
DLCO (%) | 59.33±35.00 (n=38) | |
Bronchodilator response | No | 102/143 (71.33%) |
Yes | 41/143 (28.67%) | |
Chest X-ray findings | COPD and hyperinflated | 72/227 (31.58%) |
Normal | 58/227 (25.44%) | |
COPD and bronchiectasis | 49/227 (21.49%) | |
Predominant bronchiectasis | 26/227 (11.40%) | |
COPD and cardiomegaly | 9/227 (3.95%) | |
COPD and pulmonary infiltrates | 5/227 (2.19%) | |
Nodules | 4/227 (1.75%) | |
COPD and interstitial opacity | 4/227 (1.75%) | |
Chest CT scan findings | Bronchiectasis and emphysema | 53/139 (38.12%) |
Predominant emphysema | 41/139 (29.50%) | |
Emphysema and fibrosis | 18/139 (12.95%) | |
Lung nodules | 17/139 (12.23%) | |
Normal | 10/139 (7.19%) | |
Cardiac echocardiogram findings | Normal | 35/93 (37.63%) |
Valvular anomalies | 26/93 (27.96%) | |
Pulmonary hypertension | 13/93 (13.98%) | |
Left ventricle systolic dysfunction | 11/93 (11.83%) | |
Right ventricle dysfunction | 8/93 (8.60%) | |
Blood count | Eosinophil count | 0.29±0.34 (n=187) |
Sputum culture results | Oropharyngeal flora | 66/160 (41.25%) |
Pseudomonas | 21/160 (13.13%) | |
Streptococcus pneumoniae | 5/160 (3.13%) | |
Aspergillus | 4/160 (2.50%) | |
Haemophilus influenzae | 7/160 (2.38%) | |
Staphylococcus aureus | 3/160 (1.88%) | |
NTM | 2/160 (1.25%) | |
Pseudomonas and H. influenzae | 2/160 (1.25%) | |
Pseudomonas and NTM | 1/160 (0.63%) | |
Pseudomonas and Staphylococcus | 1/160 (0.63%) | |
S. pneumoniae and H. influenzae | 1/160 (0.63%) | |
Nil | 24/160 (15.00%) | |
Other | 23/160 (14.38%) |
Abbreviations: FEV1, forced expiratory volume in one second; FVC, forced vital capacity; TLC, total lung capacity; DLCO, diffusing capacity of the lungs for carbon monoxide; COPD, chronic obstructive pulmonary disease; NTM, non-tuberculous mycobacterium.